Common use of Funded Project & Research Plan Clause in Contracts

Funded Project & Research Plan. The Funded Project is directed to identifying Genes in the Monsanto Field for application in the Monsanto Crops, and as of Collaboration Year 4, also to identifying certain types of parameters for enhancing and/or optimizing the development of products containing such Genes. As of the 2011 Signing Date, the parties agreed *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. upon an amended research plan for the Funded Project (the “Research Plan,” the form of which is attached hereto as Exhibit B). As of the 2013 Signing Date, the parties have agreed: (a) to expand the scope of the Funded Project in Collaboration Year 6, and (b) to extend the Funded Project by two additional Collaboration Years (i.e. to add Collaboration Years 7 and 8, with Data Generation activities commencing in Collaboration Year 6 and with Discovery Validation Data Backpacks and/or Project G2P Validation Data Backpacks to be finalized and delivered by Evogene to Monsanto in Collaboration Years 9 and 10), all in accordance with the numbers of Discovery Rounds and deliverables set forth in Exhibit B (collectively, the “Extended Funded Project”), which Extended Funded Project work and Research Plan, unless terminated earlier pursuant to the terms hereof, shall continue until the end of the latest-to-end Non-Disclosure Period but in any event not later than the end of Collaboration Year 10 (the “Research Period”). The Research Plan may include a general overview and timetable for development and implementation of the Funded Project, details regarding the Evogene Diligence Obligations and the Monsanto Diligence Obligations, schedules for deliverables, test protocols and procedures, thresholds for determination of a Validated Hit, procedures for disclosing and delivering Collaboration Hits, Special Collaboration Hits, and Preferred Modes of Use to Monsanto, and descriptions of other research activities. The Research Plan may be amended or supplemented by the Steering Committee from time to time, as provided below; provided, however, that to the extent any terms in the Research Plan shall at any time conflict with the terms of this Agreement, this Agreement shall control. By no later than December 31, 2013, the parties will negotiate and agree in good faith upon a further amendment and restatement of this Agreement (the “Third Amended and Restated Collaboration Agreement”) setting forth:

Funded Project & Research Plan. The Funded Project is directed to identifying Genes in the Monsanto Field for application in the Monsanto Crops, and as of Collaboration Year 4, also to identifying certain types of parameters for enhancing and/or optimizing the development of products containing such Genes. As of the 2011 Signing DateDate of this Agreement, the parties have agreed *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. upon an amended research plan for the Funded Project (the “Research Plan,” ”, the initial form of which is attached hereto as Exhibit B). As of the 2013 Signing Date, the parties have agreed: (a) to expand the scope of the Funded Project in Collaboration Year 6, and (b) to extend the Funded Project by two additional Collaboration Years (i.e. to add Collaboration Years 7 and 8, with Data Generation activities commencing in Collaboration Year 6 and with Discovery Validation Data Backpacks and/or Project G2P Validation Data Backpacks to be finalized and delivered by Evogene to Monsanto in Collaboration Years 9 and 10), all in accordance with the numbers of Discovery Rounds and deliverables set forth in Exhibit B (collectively, the “Extended Funded Project”), which Extended Funded Project work and Research PlanPlan have started as of the Effective Date, and unless terminated earlier early pursuant to the terms hereof, shall continue until the end of the latest-to-end Non-Disclosure Period but in any event not later than the end of Collaboration Year 10 8 (the “Research Period”), as may be extended in accordance with Section 5.3 if Monsanto exercises the Research Extension Option. The Research Plan may include a general overview and timetable for development and implementation of the Funded Project, details regarding the Evogene Diligence Obligations and the Monsanto Diligence Obligations, schedules for deliverables, test protocols and procedures, thresholds for determination of a Validated Hit, procedures for disclosing and delivering Collaboration Hits, Special Collaboration Hits, and Preferred Modes of Use to Monsanto, and descriptions of other research activities. Monsanto may, subject to and in accordance with Section 5.3, determine to extend the research performed by Evogene and funded by Monsanto under this Agreement, and in such event the Research Plan shall be amended as provided in Section 5.3. The Research Plan may be amended or supplemented by the Steering Committee from time to time, as provided below; provided, however, that to the extent any terms in the Research Plan shall at any time conflict with the terms of this Agreement, this Agreement shall control. By no later than December 31, 2013, the parties will negotiate and agree in good faith upon a further amendment and restatement of this Agreement (the “Third Amended and Restated Collaboration Agreement”) setting forth:.

Funded Project & Research Plan. The Funded Project is directed to identifying Genes in the Monsanto Field for application in the Monsanto Crops, and as of Collaboration Year 4, also to identifying certain types of parameters for enhancing and/or optimizing the development of products containing such Genes. As of the 2011 Signing Date, the parties agreed *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. upon an amended research plan for the Funded Project (the “Research Plan,” the form of which is attached hereto as Exhibit B). As of the 2013 Signing Date, the parties have agreed: (a) to expand the scope of the Funded Project in Collaboration Year 6, and (b) to extend the Funded Project by two additional Collaboration Years (i.e. to add Collaboration Years 7 and 8, with Data Generation activities commencing in Collaboration Year 6 and with Discovery Validation Data Backpacks and/or Project G2P Validation Data Backpacks to be finalized and delivered by *** Confidential treatment has been requested for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission. Evogene to Monsanto in Collaboration Years 9 and 10), all in accordance with the numbers of Discovery Rounds and deliverables set forth in Exhibit B (collectively, the “Extended Funded Project”), which Extended Funded Project work and Research Plan, unless terminated earlier pursuant to the terms hereof, shall continue until the end of the latest-to-end Non-Disclosure Period but in any event not later than the end of Collaboration Year 10 (the “Research Period”). The Research Plan may include a general overview and timetable for development and implementation of the Funded Project, details regarding the Evogene Diligence Obligations and the Monsanto Diligence Obligations, schedules for deliverables, test protocols and procedures, thresholds for determination of a Validated Hit, procedures for disclosing and delivering Collaboration Hits, Special Collaboration Hits, and Preferred Modes of Use to Monsanto, and descriptions of other research activities. The Research Plan may be amended or supplemented by the Steering Committee from time to time, as provided below; provided, however, that to the extent any terms in the Research Plan shall at any time conflict with the terms of this Agreement, this Agreement shall control. By no later than December 31, 2013, the parties will negotiate and agree in good faith upon a further amendment and restatement of this Agreement (the “Third Amended and Restated Collaboration Agreement”) setting forth: